ARCHIVES

NCI Advisors Approve $160-Million Network For Biomarker Discovery, Validation

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | March 13, 2009

Download PDF Visit The Full Archive

Related Articles

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

In Brief: NCHSR Says Autologous Marrow Transplant Is A “Reasonable Therapeutic Alternative”

August 11, 1989

Cancer Letter Goes On Vacation

August 16, 1985

In Brief: Weiner Elected President-Elect of AACI

February 15, 2013

Formal Guidelines For Training Grants Developed By NCI

December 7, 1979